Chargement en cours...
Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed, often without clear indications. There are conflicting data on its association with mortality risk and hepatic decompensation in cirrhotic patients. Furthermore, PPI users and PPI exposure in some studies have been poorly defined with...
Enregistré dans:
| Publié dans: | World J Gastroenterol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6737311/ https://ncbi.nlm.nih.gov/pubmed/31543684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i33.4933 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|